XML 80 R70.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation (Details)
shares in Thousands
 9 Months Ended
Sep. 30, 2023
$ / shares
shares
Stock-Based Compensation (Details)  
Stock option outstanding | shares 990
Stock option options assumed in old catheter merger | shares 753,699
Stock option options exercised | shares (402,328)
Stock option canceled/forfeited | shares (137,709)
Stock option outstanding end of the period | shares 214,652
Stock option vested and expected to vest at September 30, 2023 | shares 214,652
Stock option exercisable at September 30, 2023 | shares 214,652
Weighted average exercised price outstanding beg of period | $ / shares $ 11,405
Weighted average exercised price options assumed in old catheter merger | $ / shares 1
Weighted average exercised price Options exercised | $ / shares 1
Weighted average exercised price canceled/forfeited | $ / shares 75
Weighted average exercised price outstanding end of period | $ / shares 6
Weighted average exercised price vested and expected to vest end of the period | $ / shares 6
Weighted average exercised price exercisable at September 30, 2023 | $ / shares $ 6
Weighted Average Remaining Life end of period exercisable 6 years 7 months 6 days
Weighted Average Remaining Life Vested and expected to vest end of period 6 years 7 months 6 days
Weighted Average Remaining Life end of period 6 years 7 months 6 days